Atlas market file · Equity · United States
UnitedHealth Group IncorporatedUNH
- Last close
- 405.59
- Change
- +0.85%
- 96-bar range
- 255.97 – 461.62
- As of
- 12 Aug 2026
UnitedHealth Group Incorporated is a healthcare or life-sciences issuer listed as UNH on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- NYSE symbol identity
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-31.28% over the window).
Source rail: Yahoo Finance chart API (UNH). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for UNH. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
UNH public profile
Healthcare or life-sciences issuer. UnitedHealth Group Incorporated is connected to current market context, cited company sources and its retained research file.
UnitedHealth Group Incorporated trades as UNH on NYSE. UnitedHealth Group Incorporated (UNH) has a latest verified close of 405.59, up 0.85%, dated 12 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files UNH under USA Stocks and Healthcare & Medicine Stocks for browsing.
What changed for UnitedHealth Group Incorporated today
UnitedHealth Group Incorporated, the 800-pound gorilla of American health insurance and care delivery, just filed its March-2026 quarter and revealed a company that generates more cash than most governments, yet still treats operating cash flow like an afterthought. Revenue clocked in at $111.72 billion for the quarter, while operating income was $8.99 billion and net income attributable to the parent was $6.28 billion-numbers that would look heroic if the cash conversion weren’t so polite. Net cash provided by operating activities was $8.91 billion, a figure that sits within a rounding error of the operating income line, implying that the real business of claims adjudication, provider contracting, and regulatory compliance absorbs nearly all the economic value the top line appears to create. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/731766/000073176626000191/unh-20260716.htm)
UnitedHealth is not a tech platform; it is an administrative utility that happens to employ 400,000 clinicians, nurses, and support staff across Optum and UnitedHealthcare. The company’s balance sheet shows $312.64 billion of assets against $207.32 billion of liabilities, leaving $105.32 billion of equity and $28 billion of cash and equivalents-enough dry powder to buy a small European country or, more prosaically, to survive a year of claims inflation without blinking. Inventory of $3.30 billion (net) sits on the books at year-end 2025, which is the corporate equivalent of leaving the pharmacy fridge half-stocked while the CFO insists on a pristine cash position. (source: 10-Q, period ending 2026-03-31; 10-K, period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/731766/000073176626000191/unh-20260716.htm)
The earnings math is simple: $6.28 billion of net income divided by 910 million diluted shares gives $6.90 of EPS, a tidy figure that masks the fact that $28 billion of cash earns next to nothing while the company’s claims liabilities-its real inventory-are locked in multi-year contracts with state Medicaid programs and corporate employers. Capital expenditure for the quarter was a modest $763 million, less than 1 % of revenue, a figure that suggests maintenance capex rather than digital transformation. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/731766/000073176626000191/unh-20260716.htm)
The company’s Investor Relations page hosts an audio webcast archive, a standard investor-relations hygiene step that rarely gets more exciting than elevator music-unless, of course, the CFO decides to explain why operating cash flow trails operating income by the thickness of a claims processing queue. (source: UNH 8-K (2026-05-11), https://www.sec.gov/Archives/edgar/data/731766/000073176626000129/unh-20260511.htm)
The latest SEC Company Facts feed confirms the revenue and income line items, but the filing index shows no new segment-level breakdowns since the 2025 10-K, leaving analysts to guess how much of the $111.72 billion comes from Optum’s care-delivery units versus UnitedHealthcare’s insurance premiums. Until the next 10-K, the segment split remains a filing mystery wrapped in an earnings riddle. (source: UNH SEC EDGAR filing index, https://www.sec.gov/edgar/browse/?CIK=731766)
The company’s March 2026 10-Q is the only source of fresh financials; there is no updated forward guidance, no dividend declaration, and no buyback announcement in the evidence pack. That leaves investors to parse the gap between $8.91 billion of operating cash flow and $6.28 billion of net income-the arithmetic equivalent of watching a magician pull cash from a claims queue and then tuck it back into the queue. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/731766/000073176626000191/unh-20260716.htm)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
UNH technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on UNH
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep UNH research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
UNH FAQ
What is UnitedHealth Group Incorporated (UNH)?UnitedHealth Group Incorporated (UNH) has a latest verified close of 405.59, up 0.85%, dated 12 Aug 2026. Use this page to check the price chart, company context,...
UnitedHealth Group Incorporated (UNH) has a latest verified close of 405.59, up 0.85%, dated 12 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for UNH?UnitedHealth Group Incorporated (UNH) has a latest verified close of 405.59, up 0.85%, dated 12 Aug 2026. It brings the latest available chart, company context, cited...
UnitedHealth Group Incorporated (UNH) has a latest verified close of 405.59, up 0.85%, dated 12 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files UNH under USA Stocks and Healthcare & Medicine Stocks for browsing.
How often is the UNH page updated?The UNH public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The UNH public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for UNH?The UNH file starts with NYSE symbol identity and TradingView NYSE:UNH. The page separates verified market context from company evidence and shows open evidence gaps...
The UNH file starts with NYSE symbol identity and TradingView NYSE:UNH. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on UNH?Yes. The workstation can open UNH, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open UNH, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this UNH page investment advice?No. The UNH page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The UNH page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
UNH
Equity · evidence first